Intra-Cellular Therapies, Inc.
NOVEL METHODS

Last updated:

Abstract:

The present disclosure relates to pharmaceutical capsules comprising lumateperone, in free, or pharmaceutically acceptable salt form, optionally in combination with one or more additional therapeutic agents, processes for manufacture thereof and methods of use in the treatment or prophylaxis of disease.

Status:
Application
Type:

Utility

Filling date:

24 Jan 2022

Issue date:

12 May 2022